Eli Lilly on Thursday posted better-than-expected quarterly results, but CVS Health's decision to drop the company's obesity ...

Hyderabad has quietly outpaced India’s Silicon Valley, Bengaluru, becoming the top choice not just for tech giants, but also for professionals, entrepreneurs, and global firms looking to set up shop ...

Ladies and gentlemen, this is your captain speaking. Check your windows. Is it Dubai or what? Nah, it’s better. Welcome to ...

A big setback for former India captain and Hyderabad Cricket Association (HCA) president Mohammad Azharuddin as the association has been ordered to remove the stand named after him at the Rajiv ...

The bodies, which were to be flown out on Friday night by Air India to Hyderabad as per schedule, however, were taken on another flight of the Emirates in the early hours of Saturday and reached ...

Hyderabad Weather: The rainfall amid the scorching temperatures is normal for pre-monsoon activity. Hyderabad Weather: Providing relief from lingering heat conditions, parts of Hyderabad city were ...

A woman, Tejaswini, killed her two young sons and then jumped to her death in Hyderabad. She also left a suicide note explaining her actions. Listen to Story 32-year-old Tejaswini killed her two sons ...

Hyderabad: Hyderabad is likely to see generally cloudy skies with light to moderate rain and gusty winds (30–40 kmph) over the next 24–48 hours the India Meteorological Department (IMD) has forecasted ...

along with immunology drug Cosentyx by Novartis. CORONA Remedies, on the other hand, is tapping into the urology drug market, which was valued at $ 1.02 billion in 2024 and is anticipated to have ...

IPL 2025: Mumbai Indians will square off against Sunrisers Hyderabad in the 33rd match of the Indian Premier League (IPL) 2025 at the Wankhede Stadium in Mumbai, on Thursday, April 17th. The upcoming ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Mumbai Indians’ Suryakumar Yadav bats during the ...

He said such higher costs would "typically" lead to cuts in staff or research and development activity. Drugmakers, including Lilly, Novartis, and Johnson & Johnson, are already committing to ...